H
#CardiovascularHealth #ObesityManagement #GLP1
health.usnews.com
GLP-1 Drugs for Heart Health: Benefits, Side Effects & Who Should Take Them
Cardiologists and obesity medicine physicians alike are hopeful about these preliminary findings. However, lifestyle habits, including getting adequate sleep, eating healthy and exercising, are still the top ways to stave off cardiovascular disease.
#GLP1 #WeightLoss #DiabetesManagement
www.businessinsider.com
Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.
The pill, which analysts say might cost $300 a month, could be available as soon as mid-2026.
Better injections and better pills.
#GLP1 #WeightLoss #SexualHealth
nypost.com
Exclusive | We lost weight on GLP-1 drugs -- and then we lost our sex drives
Welcome to The Thin Line, The New York Post's series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks.
#WeightLoss #DiabetesTreatment #GLP1
nypost.com
People dropped out of Eli Lilly's new GLP-1 drug trial because they...
Participants taking the highest dose of Eli Lilly's new GLP-1 drug lost an average of 28. 7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments.
#HealthInsurance #GLP1 #ObesityTreatment
news.harvard.edu
Pricey blockbuster GLP-1s are costing users -- and most of the rest of us, too -- Harvard Gazette
Health insurers are passing along cost for coverage in form of higher rates across the board, policy researcher says
The popularity of pricey GLP-1 drugs has hit the budgets of users -- and just about everyone else.
#GLP1 #EyeHealth #MacularDegeneration
nypost.com
GLP-1s may help preserve your vision as you age -- with an important...
Could preserved vision be part of the growing list of health benefits associated with GLP-1 drug use.
New research suggests that in patients without diabetes, GLP-1 medications may lower the risk of age-related macular degeneration (AMD), the leading cause of vision loss in older US adults.
#OverdoseAwareness #ParentingSafety #GLP1Medication
people.com
Indiana Girl, 7, Hospitalized After Injecting Herself with Mom's GLP-1: 'She Didn't Eat for 6 Days'
A 7-year-old Indiana girl spent days in the hospital after overdosing on her mother's GLP-1 medication, laying there "lifeless" as her family worried for her life.
#WeightLoss #HealthTrends #GLP1
www.yahoo.com
The disruptive force of weight loss drugs: How GLP-1s do more than shed pounds
Add Yahoo as a preferred source to see more of our stories on Google.
There's no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to shed pounds or treat a chronic condition, according to a November survey by health policy organization KFF.
W
#WeightLoss #ObesityManagement #GLP1Medications
www.wsj.com
Here's What Happens When You Stop Taking Ozempic and Wegovy
Studies show that after stopping the drugs, people typically regain lost weight within about 1. 5 years. Peter Dazeley/Getty Images
A recent email ad from a telehealth company selling weight-loss medications features tennis-superstar Serena Williams.
#GLP1 #EatingDisorders #MentalHealth
nypost.com
Exclusive | GLP-1 drugs brought our eating disorders back -- and quitting the...
Welcome to The Thin Line, The New York Post's new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks.
